Search details
1.
Nivolumab in never-smokers with advanced squamous non-small cell lung cancer: Results from the Italian cohort of an expanded access program.
Tumour Biol
; 40(11): 1010428318815047, 2018 Nov.
Article
in English
| MEDLINE | ID: mdl-30486741
2.
Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases.
J Neurooncol
; 118(1): 109-16, 2014 May.
Article
in English
| MEDLINE | ID: mdl-24532241
3.
A pharmacoeconomic analysis from Italian guidelines for the management of prolactinomas.
Glob Reg Health Technol Assess
; 11: 1-16, 2024.
Article
in English
| MEDLINE | ID: mdl-38230389
4.
Italian Guidelines for the Management of Sporadic Primary Hyperparathyroidism.
Endocr Metab Immune Disord Drug Targets
; 24(8): 991-1006, 2024.
Article
in English
| MEDLINE | ID: mdl-38644730
5.
Pituitary Enlargement and Hypopituitarism in Patients Treated with Immune Checkpoint Inhibitors: Two Sides of the Same Coin?
J Pers Med
; 13(3)2023 Feb 26.
Article
in English
| MEDLINE | ID: mdl-36983597
6.
Italian Guidelines for the Management of Prolactinomas.
Endocr Metab Immune Disord Drug Targets
; 23(12): 1459-1479, 2023.
Article
in English
| MEDLINE | ID: mdl-37171003
7.
Italian Guidelines for the Management of Non-Functioning Benign and Locally Symptomatic Thyroid Nodules.
Endocr Metab Immune Disord Drug Targets
; 23(6): 876-885, 2023.
Article
in English
| MEDLINE | ID: mdl-36722479
8.
Treatment-related side effects and quality of life in cancer patients.
Support Care Cancer
; 20(10): 2553-7, 2012 Oct.
Article
in English
| MEDLINE | ID: mdl-22270087
9.
Endocrine Toxicities of Antineoplastic Therapy: The Adrenal Topic.
Cancers (Basel)
; 14(3)2022 Jan 25.
Article
in English
| MEDLINE | ID: mdl-35158860
10.
Obesity management: Attitudes and practice of Italian endocrinologists.
Front Endocrinol (Lausanne)
; 13: 1061511, 2022.
Article
in English
| MEDLINE | ID: mdl-36733804
11.
Predictors of existential and religious well-being among cancer patients.
Support Care Cancer
; 19(12): 1931-7, 2011 Dec.
Article
in English
| MEDLINE | ID: mdl-21107614
12.
Insulin Resistance as a Risk Factor for Cutaneous Melanoma. A Case Control Study and Risk-Assessment Nomograms.
Front Endocrinol (Lausanne)
; 10: 757, 2019.
Article
in English
| MEDLINE | ID: mdl-31749765
13.
Real-life results from the overall population and key subgroups within the Italian cohort of nivolumab expanded access program in non-squamous non-small cell lung cancer.
Eur J Cancer
; 123: 72-80, 2019 12.
Article
in English
| MEDLINE | ID: mdl-31671314
14.
Association of Systemic Inflammation Index and Body Mass Index with Survival in Patients with Renal Cell Cancer Treated with Nivolumab.
Clin Cancer Res
; 25(13): 3839-3846, 2019 07 01.
Article
in English
| MEDLINE | ID: mdl-30967420
15.
Targeting the PTTG1 oncogene impairs proliferation and invasiveness of melanoma cells sensitive or with acquired resistance to the BRAF inhibitor dabrafenib.
Oncotarget
; 8(69): 113472-113493, 2017 Dec 26.
Article
in English
| MEDLINE | ID: mdl-29371923
16.
Placenta growth factor and neuropilin-1 collaborate in promoting melanoma aggressiveness.
Int J Oncol
; 48(4): 1581-9, 2016 Apr.
Article
in English
| MEDLINE | ID: mdl-26846845
17.
Dermoscopic patterns of cutaneous melanoma metastases.
Melanoma Res
; 14(5): 367-73, 2004 Oct.
Article
in English
| MEDLINE | ID: mdl-15457092
18.
High expression of the mismatch repair protein MSH6 is associated with poor patient survival in melanoma.
Am J Clin Pathol
; 142(1): 121-32, 2014 Jul.
Article
in English
| MEDLINE | ID: mdl-24926095
19.
Information needs of patients with melanoma: a nursing challenge.
Clin J Oncol Nurs
; 16(6): 625-32, 2012 Dec.
Article
in English
| MEDLINE | ID: mdl-23178355
20.
Detection of circulating tumor cells is improved by drug-induced antigen up-regulation: preclinical and clinical studies.
Anticancer Res
; 30(11): 4721-30, 2010 Nov.
Article
in English
| MEDLINE | ID: mdl-21115931
Results
1 -
20
de 20
1
Next >
>>